STAT+: Centene agrees to pay $33 million to resolve another state probe into its pharmacy benefits business
Centene, one of the largest health insurers in the U.S., agreed to pay $33 million to settle allegations that its pharmacy benefits subsidiary overcharged the Washington state Medicaid program, the latest in a string of such settlements.
The deal came after a whistleblower provided information three years ago that Centene failed to disclose accurate pharmacy benefits and services as part of its contract with the state Medicaid program. The state’s Health Care Authority relied on Coordinate Care of Washington, a Centene subsidiary, to manage the Medicaid program.
